Crexont
My Prescription
Payment
Select pharmacy
$429.00
Print or send this coupon to your phone
AlbertsonsPowered byAbout Crexont
Drug Details
Crexont, a combination of carbidopa and levodopa, is an extended-release capsule specifically designed to manage symptoms of Parkinson's disease and similar conditions that cause tremors, stiffness, and movement difficulties. Parkinson's disease is associated with low levels of dopamine in the brain. Levodopa acts by converting into dopamine, thereby aiding in the control of movements. Carbidopa enhances the effectiveness of levodopa by preventing its breakdown in the bloodstream, allowing more of it to reach the brain, and also helps to reduce side effects like nausea. Typically, Crexont is administered orally two to four times daily, with the dosage tailored by your healthcare provider based on your response to the medication. Common side effects include nausea and anxiety. Always consult your doctor or pharmacist for personalized medical advice and before starting any new medication.
Price history for Crexont
90 Capsule Extended Releases, 70-280MG
Average retail price for Crexont
Average SaveHealth price for Crexont
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Crexont dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 35-140MG | 60 Capsule Extended Releases | $292.39 | $4.87 |
| 35-140MG | 120 Capsule Extended Releases | $567.79 | $4.73 |
| 52.5-210MG | 90 Capsule Extended Releases | $429.42 | $4.77 |
| 52.5-210MG | 120 Capsule Extended Releases | $566.89 | $4.72 |
| 70-280MG | 90 Capsule Extended Releases | $429.20 | $4.77 |
| 70-280MG | 120 Capsule Extended Releases | $566.60 | $4.72 |
| 87.5-350MG | 90 Capsule Extended Releases | $429.43 | $4.77 |
Crexont FAQs
Crexont is not recognized as a medication available in the United States. It is possible that it may be known under a different name or is not approved for use in the U.S. If further information is needed, consulting a healthcare professional or checking with the FDA's database for approved medications is recommended.
Rytary and Crexont are both medications used in the management of Parkinson's disease, but they differ in their formulation and release mechanisms. Rytary is an extended-release formulation of carbidopa and levodopa, designed to provide a more stable and prolonged release of the medication to help manage symptoms throughout the day. Crexont, on the other hand, is not a recognized medication name as of the latest information available. It is possible that Crexont may be a brand name not widely recognized or a typographical error. It is recommended to verify the name or consult a healthcare professional for clarification.
The generic name for Crexont is not available, as Crexont does not appear to be a recognized or approved medication. It is possible that there may be a spelling error or it could be a brand name not widely known. It is recommended to verify the spelling or provide additional context for further assistance.
As of the current knowledge, there is no information available about a medication named Crexont. It is possible that it might be a new or less-known drug, or there might be a typographical error in the name. It is recommended to verify the spelling or provide additional context for further assistance.